SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-014112
Filing Date
2023-04-28
Accepted
2023-04-28 11:55:41
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 247604
2 ex31-1.htm EX-31.1 6640
3 ex31-2.htm EX-31.2 6213
  Complete submission text file 0001493152-23-014112.txt   505666

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acut-20221231.xsd EX-101.SCH 3227
5 XBRL LABEL FILE acut-20221231_lab.xml EX-101.LAB 35680
6 XBRL PRESENTATION FILE acut-20221231_pre.xml EX-101.PRE 23370
8 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7478
Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Filer) CIK: 0001850767 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56257 | Film No.: 23862278
SIC: 2834 Pharmaceutical Preparations